Physician

Panayiotis P Grevenitis, M.D.

According to 2025 Medicare claims, Panayiotis Grevenitis, M.D. (NPI: 1073834792) practices gastroenterology in the Mobile, AL market, with the plurality of this provider's patient population coming from Mobile, AL. This provider's primary affiliated billing organization is GUT PC (NPI: 1073566006; TIN: 20-2904686) and primary practice location at 36608-1263. Grevenitis is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Grevenitis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 327 traditional Medicare patients, billed 3,341 HCPCS/CPT codes, and received $134,235 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 3,981 prescription claims across 1,014 beneficiaries totaling $1,626,997 in drug costs, led by Stelara (Ustekinumab). Open Payments data shows 134 records totaling $1,973. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $47,612 and ending at $134,235. Concurrently, Part D prescription costs have risen steadily, from $9,871 to $1,626,997. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	176	603	$47,612
2017	398	1,677	$116,924
2018	361	3,296	$124,465
2019	375	5,847	$101,363
2020	310	7,489	$98,292
2021	296	1,825	$98,544
2022	377	3,510	$145,605
2023	346	2,574	$102,851
2024	327	3,341	$134,235

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	23	79	$9,871
2016	125	354	$151,707
2017	359	1,089	$395,949
2018	371	1,381	$1,148,671
2019	471	1,557	$418,287
2020	473	1,759	$528,360
2021	574	1,946	$395,656
2022	739	2,786	$497,629
2023	861	3,530	$1,037,370
2024	1,014	3,981	$1,626,997

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	52	52	$181
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	79	79	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	150	235	$86
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	74	74	$69
45380	Biopsy of large bowel using a flexible endoscope	56	57	$67

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Stelara	Ustekinumab	11	590	$278,114
Linzess	Linaclotide	241	12,510	$219,761
Xifaxan	Rifaximin	51	1,189	$142,999
Ibsrela	Tenapanor Hcl	41	1,410	$81,117
Creon	Lipase/Protease/Amylase	29	829	$75,926

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	134	$1,973	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Panayiotis P. Grevenitis, M.D.?

Tedicare shows public-source Medicare data for Panayiotis P. Grevenitis, M.D. (NPI 1073834792), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Panayiotis P. Grevenitis, M.D. have ACO affiliation data?

Panayiotis P. Grevenitis, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Panayiotis P. Grevenitis, M.D.?

Panayiotis P. Grevenitis, M.D. is linked to GUT PC (billing NPI 1073566006) in the available physician profile data.

Does Panayiotis P. Grevenitis, M.D. have Open Payments data?

Panayiotis P. Grevenitis, M.D. has 134 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.